
Ventee 150mg Tablet XR
Marketer
Talent Healthcare
Salt Composition
Venlafaxine (150mg)
Overview Ventee 150mg Tablet XR
Axilon 150mg Extended-Release Tablets treat depression and anxiety. It modifies brain chemistry, alleviating symptoms like agitation, edginess, poor concentration, tiredness, perspiration, rapid heartbeat, and racing thoughts. Take Axilon 150mg ER with food, consistently at the same time daily for stable blood levels. If a dose is missed, take it immediately upon recall. Complete the entire course, even feeling improved; abrupt cessation may worsen symptoms. Common side effects include queasiness, vomiting, sleeplessness, reduced appetite, nervousness, constipation, increased sweating, and sexual difficulties. Dizziness and drowsiness are possible; avoid driving or demanding tasks until effects are known. These side effects typically subside. Consult your doctor if they persist or are bothersome. Before starting Axilon 150mg ER, disclose kidney, heart, liver issues, or seizure history. Report any unusual mood or behavioral shifts, worsening depression, or suicidal ideation.
Primary Ingredients of Ventee 150mg Tablet XR
No information provided. Please provide the text you wish to be rewritten.
Uses of Ventee 150mg Tablet XR
Mood disorders encompassing depressive and anxious symptoms
Major Benefits of Ventee 150mg Tablet XR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Ventee 150mg Extended-Release Tablets should be administered with a meal.
Common Side effects of Ventee 150mg Tablet XR:
- Nausea
- Vomiting
- Dizziness
- Insomnia (difficulty in sleeping)
- Decreased appetite
- Anxiety
- Constipation
- Increased sweating
- Sexual dysfunction
How to use Ventee 150mg Tablet XR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Ventee 150mg Extended-Release Tablets should be administered with a meal.
How Ventee 150mg Tablet XR works:
Extended-release Ventee 150mg tablets elevate brain levels of serotonin and noradrenaline, neurotransmitters crucial for regulating mood and mental well-being.
SAFETY ADVICE
AlcoholUNSAFE
Combining Ventee 150mg Tablet XR and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Extended-release Ventee 150mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Ventee 150mg tablets are likely unsafe for breastfeeding mothers. Studies in humans indicate potential transfer of the medication into breast milk, posing a risk to the infant. Infants should be observed for drowsiness and monitored to ensure appropriate weight gain.
DrivingUNSAFE
Driving ability may be impaired by Ventee 150mg XR tablets, due to potential side effects including dizziness, confusion, and visual disturbances like blurred vision.
KidneyCAUTION
Extended-release Ventee 150mg tablets require careful administration for individuals with impaired kidney function. Dosage modification of Ventee 150mg extended-release tablets might be necessary. Physician consultation is recommended.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Ventee 150mg extended-release tablets. Dosage modification of Ventee 150mg extended-release tablets may be necessary. Physician consultation is advised.
What if you forget to take Ventee 150mg Tablet XR :
Should you forget a Ventee 150mg Extended-Release Tablet, ingest it immediately upon recollection. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ventee 150mg Tablet XR
| Label | Value |
|---|---|
| Chemical Type | Anisole-based compound |
| Developing Habits | No. |
| Treatment Category | Central Nervous System (CNS) |
| Actions | SNRIs (serotonin-norepinephrine reuptake inhibitors) |
